The present data raise the possibility that FGFR3 has biphasic effects during multistage carcinogenesis in carcinomas, acting first as a tumor suppressor through oncogene-induced senescence via STATs activation and apoptosis enhancement. Here, FGFR3 is linked to carcinoma.